Boryung said Monday that it would strive further to localize and stabilize the supply of anticancer drugs following the adjustment of drug prices for its anticancer drugs EPS Injection and Epirubicin Hcl Injection Boryung.

According to a partial revision of the "Pharmaceutical Reimbursement List and Upper Limit Amount Table” announced recently by the Ministry of Health and Welfare, the drug prices of Boryung's EPS Injection (etoposide) and Epirubicin Hcl (epirubicin) Injection Boryung were raised on Oct. 1.

EPS and Epirubicin Hcl are essential drugs used to treat various cancers, including malignant lymphoma and lung cancer. Boryung's drugs are the only ones currently being produced with these ingredients.

Both products have a production cost exceeding 100 percent of sales but Boryung has maintained production despite poor profitability for cancer patients, who will suffer if the supply of these products is interrupted.

The price adjustments were made based on social consensus on the need for a stable supply of essential drugs, and institutional support from related organizations, such as the Health Insurance Review and Assessment Service and the National Health Insurance Service, also played a role.

Industry watchers said that with this move, Boryung will be able to continue supplying both products to patients.

Based on its sense of social responsibility, Boryung has worked to ensure a stable supply of anticancer drugs, the company said, adding that it would continue to focus on developing K-cancer drugs, including innovative new drugs and generic drugs, supplying essential anticancer drugs, acquiring global drugs, and sourcing new drugs from overseas to provide various cancer treatment options.

“Through this price adjustment, we will be able to provide essential basic anticancer drugs to patients without any disruption,” said Kim Young-suk, head of the Boryung Onco Division. ‘We will continue to play a pivotal role in building a drug safety net based on our mission of ’localizing anticancer drugs and providing stable supply.